Evaluation of Fixed Dose Combination Perindopril/Amlodipine Influence on Target Organ Damage in Patients with Arterial Hypertension and Ischemic Heart Disease (Results of EPHES Trial)

HYPERTENSION ◽  
2016 ◽  
Vol 0 (2.46) ◽  
pp. 77
Author(s):  
H.D. Radchenko ◽  
L.O. Mushtenko ◽  
O.O. Torbas ◽  
S.M. Kushnir ◽  
O.A. Yarynkina ◽  
...  
2020 ◽  
pp. 74-78
Author(s):  
V. P. Mikhin

The article substantiates the feasibility of combination antihypertensive therapy in patients with arterial hypertension without target organ damage and high cardiovascular risk. The authors consider a clinical case of the use of amlodipine and losartan in a fixed-dose combination (Lozap AM) as part of complex therapy in a patient with arterial hypertension, dyslipidemia and obesity. The clinical case showed the ability of the drug to both achieve a steady level of target blood pressure and improve its daily profile by transferring the Night-peaker type to the Non-dipper type.


Kardiologiia ◽  
2019 ◽  
Vol 59 (1) ◽  
pp. 22-27 ◽  
Author(s):  
N. V. Drobotya ◽  
S. S. Torosyan ◽  
E. Sh. Guseynova ◽  
M. N. Morgunov

In a group of 32 patients with combined ischemic heart disease (IHD) and arterial hypertension (AH) we studied dynamics of parameters of blood pressure and ECG 24-hour monitoring, as well as ultrasound structural and functional parameters of left and right ventricles during 3-month therapy with fixed dose combination of perindopril arginine (10.0 mg) and amlodipine (5.0 mg). The obtained results demonstrated significant positive effect of this combination on the geometry, structure and diastolic function of both left and right ventricles, as well as confirmed its high antiischemic and antihypertensive effects.


Sign in / Sign up

Export Citation Format

Share Document